| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016583 | HBV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS10028803 | HBV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS10032590 | HBV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS10041940 | HBV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS30077731 | HIV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS30052203 | HIV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS30052204 | HIV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS20055334 | HPV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS20055214 | HPV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
| TVIS20036711 | HPV | ENSG00000204217.16 | protein_coding | BMPR2 | No | No | 659 | Q13873 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BMPR2 |
|---|---|
| DrugBank ID | DB11639 |
| Drug Name | Dibotermin alfa |
| Target ID | BE0009324 |
| UniProt ID | Q13873 |
| Regulation Type | ligand |
| PubMed IDs | 12473698; 19707367 |
| Citations | Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002 Dec;84-A(12):2123-34.@@Ghodadra N, Singh K: Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biologics. 2008 Sep;2(3):345-54. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
